Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Nature of Business (Details)

v3.22.0.1
Nature of Business (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Write off of COVID-19 PCR testing inventory and equipment   $ 6,100 $ 6,061 $ 0 $ 0
Write off of remaining COVID-19 PCR testing inventory     5,300    
PCR testing equipment, general and administrative     800    
Grant income recognized, COVID-19     0 7,900 $ 0
Accrued deferred social security taxes, COVID-19 $ 3,000   $ 3,000 5,900  
Amount of ERTC recognized, COVID-19 $ 4,400     $ 1,900